Original Research
Published on 05 Mar 2021
Development of a Genomic Signatures-Based Predictor of Initial Platinum-Resistance in Advanced High-Grade Serous Ovarian Cancer Patients
in Women's Cancer
Frontiers in Oncology
doi 10.3389/fonc.2020.625866
- 6,097 views
- 16 citations
